(Q42203535)

English

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

scientific article published on 19 August 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shasha Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Yu Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Qitian Mu

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Lihong Cao

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Jian Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Zhijuan Zhu

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Yinjun Lou

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Haitao Meng

8

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Wenbin Qian

9

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hongyan Tong

10

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Wenyuan Mai

11

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Jian Huang

12

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Wenjuan Yu

13

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Xiaoying Zhao

14

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Jie Jin

15

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

publication date

19 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1027-1032

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Management of viral hepatitis in hematologic malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.947606

21 January 2018

Identifiers

10.3109/10428194.2014.947606

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42203535&oldid=2103427422"